Skip to main content

Notice of Intent - Illumina MiSeq i100 series instruments

Department of Health and Human Services, National Institutes of Health

Deadline
November 27, 20266 days left
Contract value
Value not stated in the noticeTypical award, not this listing's figure
Set-aside
None stated

What it is

This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Illumina, Inc. Acquisition Description: The purpose of this acquisition is to purchase two Illumina MiSeq i100 series instruments. These instruments will be used by the NIH HLA Laboratory to produce high resolution HLA typing results for the numerous transplant protocols supported by the…

From the official listing, in the buyer's own words.

Who can bid

  • Businesses registered to sell to this buyer

The notice names no set-aside, so it is not limited to one type of firm.

What it is worth

Value not stated in the notice

Typical award, from past awards: Similar NAICS 334516 contracts from this agency were awarded for $20K to $112K (middle half of 5684 awards, 2023 to 2026). This notice does not state its own value.

Source: public award records

Notice details

Notice type
Presolicitation
Solicitation number
NOI-OLAO-CC-27-000836
Line of work
IT
NAICS
334516

Rules on AI-written applications

Funder restricts AI-written applications

NIH will not consider applications that are substantially developed by AI to be original ideas of applicants, and says it uses detection technology and may refer AI-generated applications found after award for research-misconduct review. Notice NOT-OD-25-132 (released 2025-07-17, applies from the 2025-09-25 receipt date) also caps applications at six per PI per year. It does not require disclosure of AI use.

Source: National Institutes of Health (NIH), checked Nov 21, 2026